We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue
Abbott Diagnostics

Download Mobile App




Events

more events
ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
11 Aug 2020 - 13 Aug 2020
Virtual Venue
SAGES 2020 - Annual Meeting of the Society of American Gastrointestinal and Endoscopic Surgeons
20 Aug 2020 - 23 Aug 2020
Virtual Venue
WCO-IOF-ESCEO 2020 - World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
29 Aug 2020 - 02 Sep 2020
Virtual Venue
ESC Congress 2020 – European Society of Cardiology

In Other News

Illustration

NIH Clinical Trial to Evaluate Antibodies and Experimental Therapeutics for COVID-19

The National Institutes of Health (NIH Bethesda, MA, USA) has launched a Phase 2 clinical trial to evaluate the safety and efficacy of potential new therapeutics for COVID-19, including an investigational therapeutic based on synthetic monoclonal antibodies (mAbs) to treat the disease. Read more
06 Aug 2020 | COVID-19
Image: Johnson & Johnson to Supply US Government with 100 Million Doses of Investigational COVID-19 Vaccine (Photo courtesy of Johnson & Johnson)

Johnson & Johnson to Supply US Government with 100 Million Doses of Investigational COVID-19 Vaccine

Johnson & Johnson’s (New Brunswick, NJ, USA) Janssen Pharmaceutical Companies have entered into an agreement with the US government for the large scale domestic manufacturing and delivery in the US of 100 million doses of Janssen's SARS-CoV-2 investigational vaccine, Ad26. Read more
06 Aug 2020 | COVID-19
Image: Novavax COVID-19 Vaccine Elicits Wild-Type Virus Neutralizing Antibody Responses in 100% of Participants in Phase 1/2 Trial (Photo courtesy of Novavax, Inc.)

Novavax COVID-19 Vaccine Elicits Wild-Type Virus Neutralizing Antibody Responses in 100% of Participants in Phase 1/2 Trial

Novavax, Inc. (Gaithersburg, MD, USA) has announced positive Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of its COVID‑19 vaccine with and without Matrix‑M adjuvant in healthy adults 18-59 years of age. Read more
06 Aug 2020 | COVID-19
Illustration

BioNTech Begins Phase 1 Trial of mRNA-based COVID-19 Vaccine Candidate with Fosun Pharma in China

Biopharmaceutical New Technologies (BioNTech Mainz, Germany) and Fosun Pharma (Shanghai, China) have initiated a Phase 1 study to evaluate the safety and immunogenicity of their mRNA-based COVID-19 vaccine candidate in Chinese participants to support potential regulatory approval pathway in China. Read more
06 Aug 2020 | COVID-19
Illustration

FDA Could Issue Emergency Use Authorization for COVID-19 Vaccine Within Weeks After Clinical Trial Data Meet Efficacy Requirements

The US Food and Drug Administration (FDA Silver Spring, MD, USA) could issue an emergency use authorization (EUA) for a COVID-19 vaccine in a “matter of weeks” after clinical trial data meet efficacy requirements, according to a top FDA official. Read more
05 Aug 2020 | COVID-19
Illustration

First Molecular T Cell Monitoring Tool for SARS-CoV-2 Launched

Adaptive Biotechnologies (Seattle, WA, USA) has launched immunoSEQ T-MAP COVID, a proprietary research product and data analysis service to accurately and reproducibly measure the T-cell immune response to vaccines in development and track the persistence of that response over time. Read more
05 Aug 2020 | COVID-19
Illustration

Potential Medical Solution Utilizes Nanobody Technology for Detection and Treatment of COVID-19

Scientists are developing a potential medical solution that utilizes nanobody technology for both the detection as well as treatment of COVID-19. Read more
05 Aug 2020 | COVID-19
Illustration

Regeneron’s COVID-19 Antibody Drug Cocktail Completely Blocks Coronavirus Infection in Animal Test

Regeneron Pharmaceuticals, Inc.’s (Tarrytown, NY, USA) COVID-19 antibody drug combination has prevented as well as treated the disease in rhesus macaques and hamsters, raising hopes of the cocktail treatment working for humans as well. Read more
05 Aug 2020 | COVID-19
Illustration

Slight Variability in Coronavirus Mutations Could Make COVID-19 Vaccine Effective Against All SARS-CoV-2 Strains

Researchers have found that the SARS-CoV-2 virus, which presents at least six strains, shows little variability despite its mutations, suggesting that the mutations do not impinge on the process of developing effective COVID-19 vaccines. Read more
05 Aug 2020 | COVID-19
Image: Imperial College Begins Immunizing Hundreds of People with Experimental COVID-19 Vaccine in Early Trial (Photo courtesy of Imperial College London)

Imperial College Begins Immunizing Hundreds of People with Experimental COVID-19 Vaccine in Early Trial

Scientists at the Imperial College London (London, UK) are immunizing hundreds of people with their experimental coronavirus vaccine in an early trial after a small number of volunteers who had been vaccinated did not show any worrying safety problems. Read more
04 Aug 2020 | COVID-19
Image: COVID-19 Vaccine Could Give Immunity for At Least 12 Months, Says AstraZeneca (Photo courtesy of AstraZeneca)

COVID-19 Vaccine Could Give Immunity for At Least 12 Months, Says AstraZeneca

The COVID-19 vaccine could give immunity from the coronavirus for at least 12 months or even provide two years of protection, according to the chief behind AstraZeneca’s (Cambridgeshire, England) trial. Read more
04 Aug 2020 | COVID-19
Image: Researchers Testing Do-It-Yourself COVID-19 Vaccine on Themselves (Photo courtesy of RaDVaC)

Researchers Testing Do-It-Yourself COVID-19 Vaccine on Themselves

A group of researchers have formed the Rapid Deployment Vaccine Collaborative (RaDVaC), developed their own do-it-yourself COVID-19 vaccine and begun testing the vaccine on themselves. Read more
04 Aug 2020 | COVID-19

Channels

AI

view channel
Cybersecurity Service Protects Medical Devices from Attacks
Artificial Intelligence Can Detect Glucose Levels via ECG
AI Outperforms Humans in Diagnosis of Skin Lesions
Image: AI enhance facial recognition algorithms can identify people wearing masks (Photo courtesy of Herta)

New Technology Allows Identification Through a Mask

Following the worldwide outbreak of coronavirus, an improved facial recognition solution can correctly identify people who wear facial masks. The Herta (Barcelona, Spain) facial recognition algorithms... Read more

Critical Care

view channel
Medical Grade Terminal Assists Healthcare Facilities
Disposable Medical Biosensor Monitors Patients Remotely
Decontamination May Damage N95 Face Masks' Integrity
Image: Inside view of the mouthpiece and non-woven paper cover (Photo courtesy of Hiroyuki Endo)

Disposable Covering Protects Endoscopists Against COVID-19

A novel nonwoven fabric device helps prevent diffusion of aerosol droplets from people undergoing esophagogastroduodenoscopy (EGD) during the COVID‐19 pandemic. Developed at Tohoku University (Japan),... Read more

Surgical Techniques

view channel
LAA Closure Device Reduces Stroke Risk
Preoperative Brain Mapping Can Protect Language Centers
Axillary Vein Approach Superior for ICD Leads Placement
Image: The Ellipsys Vascular Access System (Photo courtesy of Avenu Medical)

Vascular Access System Creates Durable AVF for Hemodialysis

A novel device uses a small needle puncture and a catheter to create a percutaneous arteriovenous fistula (pAVF) for end-stage renal disease (ESRD) patients who require hemodialysis. The Avenu Medical... Read more

Women's Health

view channel
Nitrous Oxide Use During Labor Is Safe
Mobile Phone App Determines Risk of Preterm Birth
Routine Screening Prevents Majority of Cervical Cancers
Image: Menopause is a risk factor for metabolic syndrome (Photo courtesy of Getty Images)

Menopause Can Increase Risk of Metabolic Syndrome

A new study identifies menopause as a risk factor for the development of metabolic syndrome (MTS) or its components, such as hypertension and high blood sugar. Researchers at St. Michael’s Hospital... Read more

Patient Care

view channel
Touchless Tool Limits Exposure to Pathogens
Non-Invasive Ventilation Device Helps Maintain Oral Care
Vagal Nerve Stimulation Helps Treat Chronic Pain
Image: A new nickel foam filter can kill SARS-CoV-2 in seconds (Photo courtesy of UH)

Heated Air Filter Kills SARS-CoV-2 Instantly

A new “catch and kill” air filter made of nickel foam can trap the virus responsible for COVID-19, killing it instantly, claims a new study. Developed at the University of Houston (UH; TX, USA), Medistar... Read more

Health IT

view channel
Wireless-Controlled Soft Neural Implant Stimulates Brain Cells
Tiny Polymer Stent Could Treat Pediatric Urethral Strictures
Human Torso Simulator Helps Design Brace Innovations
Image: Data for active cases in severely affected countries with Equation (Photo courtesy of Frontiers)

Statistical Tool Predicts COVID-19 Peaks Worldwide

A new study shows how a unique set of functions and probability distributions can predict forthcoming peaks in the spread of COVID-19. Developed by researchers at Santa Fe Institute (NM, USA), Ege... Read more

Business

view channel
MEDICAL FAIR ASIA 2020 Set to Take Place in Singapore from 9-11 December 2020
Nova's Stat EMS Basic Blood Testing System Launched in CE Mark Countries
Nova's Stat Profile Prime Plus Blood Gas Analyzer Receives FDA Clearance for POC...
Illustration

Omnia Health Live Unites Global Healthcare Community Through New Virtual Experience

Omnia Health Live, a virtual healthcare event, has brought the global healthcare community together on a scale never seen before through a new experience delivered entirely online. The virtual healthcare... Read more

HospiMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Cookie Policy
Journal Info
Contact Us

Channels

AI
Critical Care
Surgical Techniques
Women's Health
Patient Care
Health IT
Business
Events

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

TradeMed.comMedImaging.netLabMedica.com Globetech.net

Archive:

2020
ARAB HEALTH 2020 2019
Medica 2019 ECR 2019 ARAB HEALTH 2019 2018
Medica 2018 ARAB HEALTH 2018 2017
Medica 2017 ARAB HEALTH 2017

 

2016
Medica 2016
Copyright © 2000-2020 Globetech Media. All rights reserved.
MOBILE | FULL SITE